CU-Boulder technology used to identify unexpected bacteria in cystic fibrosis patients

December 3, 2007

Molecular technology developed by a University of Colorado at Boulder professor to probe extreme life forms in undersea hydrothermal vents has been used to identify unexpected bacteria strains in the lung fluid of Denver children suffering from cystic fibrosis, findings that may lead to more effective therapies.

Instead of standard culturing techniques, researchers used nucleic acid gene sequencing to rapidly detect, identify and classify pathogens found in the lungs of cystic fibrosis sufferers, said CU-Boulder Professor Norman Pace, who pioneered the method in the 1990s using microbes from Pacific Ocean hydrothermal vents. Pace and his colleagues at CU-Denver's Health Sciences Center and Denver's Children's Hospital identified more than 60 species of bacteria in samples of 28 cystic fibrosis patients in Denver. Thirteen samples contained bacteria that are not routinely assessed by culturing.

The presence of the unexpected bacteria may help explain cases of unidentified lung inflammation and the consequent failure of patients -- primarily children -- to respond to standard treatments, said Pace. "The results show molecular sequencing is a more effective, faster and far less expensive way to assess airway bacteria than routine clinical cultures and better identifies targets for further clinical evaluation," said Pace.

Cystic fibrosis, a life-threatening genetic disease affecting about 30,000 people in the United States, is marked by a build-up of mucus in the lungs and pancreas that can clog organs, according to the Cystic Fibrosis Foundation. In addition to causing difficulty breathing, the thick mucus acts as a breeding ground for bacteria in the lungs that causes swelling, inflammation and infections that can lead to lung damage. Most deaths from cystic fibrosis are caused by such infections, said Pace.

A paper on the subject was published the week of Dec. 3 in the Proceedings of the National Academy of Sciences. Co-authors on the study included Kirk Harris and Mary Ann De Groote of CU-Boulder's MCD biology department, Scott Sagel, Edith Zemanick, Robin Deterding and Frank Acurso of CU-Denver's Health Sciences Center and Robert Kapsner, Churee Penvari and Heidi Kaess of the Mike McMorris Cystic Fibrosis Research and Treatment Center at Denver's Children's Hospital.

About 80 percent of pathogens identified in cystic fibrosis patients using the novel gene sequencing technology belong to three common bacterial groups, including the group that causes strep infections, said Pace. But the remaining 20 percent were from unexpected bacterial strains that would not normally be cultured in cystic fibrosis lab tests.

In one child in the test group, all of the pathogens in the mucus were from a bacterium genus known as "Lysobacter," which is commonly found in soils but not tested for in humans through standard cultures. "In cases like this, doctors could go back and re-test individual children for specific bacterial infections," he said. "This would be another advantage for clinicians using this technology for cystic fibrosis patients."

Pace said the molecular method involves isolating and amplifying bacterial nucleic acid samples from the lung fluids, then sequencing them to census individual pathogens by where they fit on the phylogenetic, or family, tree.

"This is a great example of a successful research collaboration between campuses in the University of Colorado system," said Pace a member of the National Academy of Sciences and 2001 winner of a $500,000 MacArthur Foundation Fellowship, popularly known as the "genius grant." "My feeling is that those involved in cystic fibrosis research internationally will be very interested in these findings."

Source: University of Colorado at Boulder

Explore further: Stripping away an infection's armour

Related Stories

Stripping away an infection's armour

January 12, 2017

A Massey professor of microbiology has identified a protein that could help fight serious infections in elderly, cancer, HIV and cystic fibrosis patients.

Scientists discover how bacteria induce 'NET' release

November 17, 2016

Flagellar motility of Pseudomonas aeruginosa is the main factor required to induce the release of neutrophil extracellular traps (NETs), according to a study published November 17, 2016 in the open-access journal PLOS Pathogens ...

Protein disrupts infectious biofilms

December 8, 2016

Many infectious pathogens are difficult to treat because they develop into biofilms, layers of metabolically active but slowly growing bacteria embedded in a protective layer of slime, which are inherently more resistant ...

Researchers develop novel wound-healing technology

November 29, 2016

A WSU research team has successfully used a mild electric current to take on and beat drug-resistant bacterial infections, a technology that may eventually be used to treat chronic wound infections.

Recommended for you

Synthetic chemicals: Ignored agents of global change

January 24, 2017

Despite a steady rise in the manufacture and release of synthetic chemicals, research on the ecological effects of pharmaceuticals, pesticides, and industrial chemicals is severely lacking. This blind spot undermines efforts ...

80-million-year-old dinosaur collagen confirmed

January 23, 2017

Utilizing the most rigorous testing methods to date, researchers from North Carolina State University have isolated additional collagen peptides from an 80-million-year-old Brachylophosaurus. The work lends further support ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.